For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Skye Pharma, Inc.

USPTO Granted Patents = 13

% Expired Patents = 7.7

Trademarks = 2

Forward Citations = 688

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Mantripragada Bhima Sankaram (9 out of 10 patents)

Qiang Ye (5 out of 42 patents)

Sinil Kim (5 out of 26 patents)

4. Taehee Kim (2 out of 7 patents)

5. Rudolf Edgar Falk (1 out of 33 patents)

6. Sharad B Murdande (1 out of 2 patents)

7. Andres Gruber (1 out of 2 patents)

8. Nandini Katre (1 out of 2 patents)

9. Samuel Simon Asculai (1 out of 38 patents)

10. Alan L Russell (1 out of 1 patent)

11. Stephen B Howell (1 out of 18 patents)

12. Sharad Murdandi (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 6793938 - Biodegradable compositions for the controlled release of encapsulated substances (2004-09-21),

2. 6428529 - Epidural administration of therapeutic compounds with sustained rate of release (2002-08-06),

3. 6277413 - Biodegradable compositions for the controlled release of encapsulated substances (2001-08-21),

4. 6241999 - Method for producing liposomes with increased percent of compound encapsulated (2001-06-05),

5. 6193998 - Method for producing liposomes with increased percent of compound encapsulated (2001-02-27),

6. 6171613 - Method for producing liposomes with increased percent of compound encapsulated (2001-01-09),

7. 6159955 - Use of hyaluronic acid and a NSAID for the manufacture of a medicament (2000-12-12),

8. 6132766 - Multivesicular liposomes with controlled release of encapsulated (2000-10-17),

9. 6106858 - Modulation of drug loading in multivescular liposomes (2000-08-22),

10. 6071534 - Multivesicular liposomes with controlled release of active agents (2000-06-06),

11. 6045824 - Sustained-release liposomal anesthetic compositions (2000-04-04),

12. 5997899 - Method for producing liposomes with increased percent of compound (1999-12-07),

13. 5993850 - Preparation of multivesicular liposomes for controlled release of (1999-11-30),

Skye Pharma, Inc. is a leading pharmaceutical company specializing in developing innovative drug delivery technologies. With a focus on improving patient outcomes and convenience, Skye Pharma is dedicated to delivering cutting-edge solutions in various therapeutic areas. Their commitment to research and development drives their success in bringing new and improved treatments to the market, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#410 in San Diego, CA

#5,648 in California

#23,808 in US

#44,950 in the World

San Diego, CA, United States of America

Skye Pharma, Inc.

Forward Citations = 688

12 inventors:

Mantripragada Bhima Sankaram (9 out of 10 patents)

Qiang Ye (5 out of 42 patents)

Sinil Kim (5 out of 26 patents)

4. Taehee Kim (2 out of 7 patents)

5. Rudolf Edgar Falk (1 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…